학술논문
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease
Document Type
Article
Author
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, March 2022, 55(5):593-603)
Subject
Language
English
ISSN
13652036
02692813
02692813